MAMelissa Rodrigues de Araujo

Melissa Rodrigues de Araujo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Melissa Rodrigues de Araujo has a total of 189 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Extraoral Versus Intraoral Photobiomodulation for the Prevention of Oral Mucositis in Pediatric Patients Undergoing High‐Dose Methotrexate Chemotherapy

    by Mariana Lena Sassi, Nicoly Ghilardi Cardoso, Rafael Zancan Mobile, Bruna da Fonseca Wastner, Mara Albonei Dudeque Pianovski, Robinson Sabino‐Silva, Marco Guevara‐Vega, Douglas Carvalho Caixeta, Laurindo Moacir Sassi, Melissa Rodrigues de Araujo

    Aims: To compare intraoral (IO) and extraoral (EO) photobiomodulation therapy (PBMT) for preventing oral mucositis (OM) in pediatric patients receiving high‐dose methotrexate (HD‐MTX). Methods and Results: This prospective, open‐label, randomized clinical trial included 75 HD‐MTX treatment episodes from 31 pediatric patients aged 1–18 years. Each episode was randomized to IO‐PBMT or EO‐PBMT with red light at 660 nm. Preventive PBMT was initiated before HD‐MTX infusion and administered daily until discharge. OM was assessed at baseline and on days 3, 5, and 10 using the World Health Organization scale. Pain, salivary pH, and salivary biochemical profiles were secondary or exploratory outcomes. Cumulative OM occurred in 22/37 IO‐PBMT episodes (59.5%) and 12/38 EO‐PBMT episodes (31.6%). After accounting for repeated episodes within patients, OM risk was higher with IO‐PBMT (risk ratio, 1.84; 95% CI, 1.07–3.19; p = 0.029). Pain scores, salivary pH, and biochemical profiles did not differ significantly between groups. EO‐PBMT required substantially less application time, and no adverse effects were reported. Conclusion: EO‐PBMT was associated with lower cumulative OM occurrence, shorter application time, and good tolerability, supporting its use as a promising, less burdensome preventive strategy in pediatric oncology.

  • Open Access

    Comparable efficacy of extraoral and intraoral photobiomodulation in preventing oral mucositis during high-dose methotrexate therapy in pediatric oncology: A single-blind randomized controlled trial

    by Isabela de Oliveira Plugge Freitas, Isabela Schuartz, Giovanna Leal Klein Renz, Rafael Zancan Mobile, Mariana Lena Sassi França, Mara Albonei Dudeque Pianovski, Laurindo Moacir Sassi, Melissa Rodrigues de Araujo

    Purpose: This prospective randomized controlled clinical study compared intraoral (IO) and extraoral (EO) photobiomodulation (PBM) for the prevention of chemotherapy-induced oral mucositis (OM) in pediatric oncology patients. Methods: A total of 155 patients (1–18 years), receiving high-dose methotrexate (HDMTX) for leukemia, lymphoma, or osteosarcoma, were randomized to PBM-IO ( n = 73) or PBM-EO ( n = 82). Preventive PBM was administered daily from hospital admission through discharge. Both protocols used red light with equivalent dosimetry (660 nm, 100 mW, 1 J per point). PBM-EO required 30 s/session, whereas PBM-IO required approximately 6 min, excluding patient handling time. OM occurrence, severity (WHO scale), plaque index, and pain (numeric rating scale) were assessed on days 0, 3, 5, and 10 after HDMTX infusion. Results: The overall OM occurrence was 35.5%, with no significant difference between PBM-IO (41.1%) and PBM-EO (30.5%) groups ( p = 0.168). No statistically significant differences were observed between groups for OM severity, pain, salivary pH, or plaque index at any time point ( p > 0.05). Multivariable ordinal logistic regression demonstrated that PBM modality was not independently associated with OM severity. As expected, increasing age (OR = 1.14; 95% CI: 1.04–1.25; p = 0.004) and higher HDMTX dose (OR = 1.24; 95% CI: 1.03–1.49; p = 0.021) were significantly associated with greater OM severity. Median pain scores remained 0 at all assessment points in both groups. Conclusion: Extraoral PBM demonstrated comparable effectiveness to intraoral for OM prevention in pediatric patients undergoing HDMTX chemotherapy, while reducing application time.

  • Open Access

    Acceptance and perceived efficacy of intraoral versus extraoral photobiomodulation for oral mucositis prevention in pediatric patients

    by Isabela de Oliveira Plugge Freitas, Giovanna Leal Klein Renz, Isabela Schuartz, Mara Albonei Dudeque Pianovski, Laurindo Moacir Sassi, Bruna da Fonseca Wastner, Melissa Rodrigues de Araujo

    Objective: To compare acceptance, tolerability, and perceived efficacy of extraoral (EO) and intraoral (IO) photobiomodulation therapy (PBMT) for oral mucositis (OM) prevention in pediatric oncology patients. Methods: Caregivers of 32 pediatric patients undergoing chemotherapy completed a structured questionnaire after their children experienced both intraoral and extraoral PBMT for oral mucositis prevention during different chemotherapy cycles within a randomized clinical study. Device preference, discomfort, perceived pain control, and reasons for preference were descriptively analyzed. Results: EO-PBMT was preferred by 65.6% of respondents, whereas 34.4% preferred IO-PBMT. Preference for EO-PBMT was mainly associated with greater comfort and avoidance of mouth opening. Discomfort was reported by 43.8% during IO-PBM and by 6.3% during EO-PBMT, with a statistically significant difference between the modalities ( p = 0.001). IO-PBMT was more often perceived to provide better pain control (34.4%), whereas 12.5% favored EO-PBMT. Conclusion: EO-PBMT demonstrated greater caregiver acceptance and lower treatment-related discomfort than IO-PBMT. Although caregivers more frequently perceived IO-PBMT as providing better pain control, these subjective perceptions did not correspond to differences in the clinical occurrence or severity of OM between treatment modalities. EO-PBMT therefore represents a feasible and well-accepted approach for supportive care in pediatric oncology.

  • Open Access

    Comparative efficacy of two photobiomodulation protocols transcutaneous versus intraoral in the prevention of oral mucositis in head and neck cancer: a randomized study protocol

    by Waleska Tychanowicz Kolodziejwski, Giovanna Leal Klein Renz, Isabela Busnello de Souza, Maria Luisa Franceschi Coimbra, Luciana Almeida Lopes, Laurindo Moacir Sassi, Melissa Rodrigues de Araujo

    This study aims to compare the clinical efficacy of transcutaneous photobiomodulation (PBMT) with an 808 nm infrared laser versus intraoral PBMT with a 660 nm red laser in the prevention of oral mucositis (OM). The study is designed to assess whether the transcutaneous approach is non-inferior to the intraoral standard, thereby contributing to the optimization and standardization of PBMT protocols in head and neck cancer (HNC) supportive care. Methods: A randomized pilot study is being conducted with 54 patients ( n = 27 per group) undergoing radiotherapy (60–70 Gy) for HNC. Participants will be randomly assigned to receive either intraoral PBMT (660 nm, 100 mW, 1 J/point, fluence = 10.20 J/ cm², 10 s, 44 points) or transcutaneous PBMT (808 nm, 100 mW, 1 J/point, fluence = 34.5 J/ cm² (central) and 4.3 J/ cm² (lateral), 10 s, 32 points). Interventions occur three times weekly throughout treatment. The primary outcome is OM severity, graded by WHO scale. Secondary outcomes include OM severity (NCI-CTCAE), pain intensity (Numeric Rating Scale, NRS), ulcerated area extension, registered through digital images, treatment interruptions and unscheduled healthcare utilization. Expected outcomes: the primary hypothesis posits that transcutaneous infrared PBMT is as effective as intraoral red PBMT in mitigating OM severity. Additionally, the transcutaneous approach is expected to offer logistical advantages, including a reduction in application time (80 s vs. 440 s) and improved tolerability in patients with radiation-induced trismus or severe oral pain. Conclusion: This protocol is expected to provide robust evidence to support the most feasible and effective PBMT modality for OM prevention. By optimizing treatment delivery, the study may enhance adherence, preserve nutritional status, and improve the quality of life for patients undergoing oncological therapy.


  • Open Access

    Intraoral and transcutaneous photobiomodulation protocol for hyposalivation in head and neck cancer patients undergoing radiotherapy: a study protocol

    by Giovanna Leal Klein Renz, Waleska Tychanowicz Kolodziejwski, Isabela Busnello de Souza, Laurindo Moacir Sassi, Luciana Almeida-Lopes, Melissa Rodrigues de Araujo

    Introduction: Hyposalivation is a common complication in patients undergoing head and neck radiotherapy. It negatively affects quality of life and increases the risk of secondary conditions such as dental caries, opportunistic infections, and nutritional impairment. Photobiomodulation (PBM) has been proposed as a preventive strategy; however, there is no consensus regarding the optimal protocol or the most appropriate route of application. Methods: This pilot study aims to compare the efficacy of intraoral and transcutaneous PBM in preventing radiotherapy-induced hyposalivation. The intraoral protocol will use a 660 nm red laser (100 mW, 1 J, 10 s per point, 10.02 J/cm², total 44 points). The transcutaneous protocol will use an 808 nm infrared laser (100 mW, 1 J, 10 s per point, total 32 points). The intraoral approach will deliver targeted irradiation to oral tissues, while the transcutaneous approach will deliver infrared irradiation externally, taking advantage of its greater tissue penetration and potentially improved patient comfort. Outcomes: The primary outcome will be the incidence of stimulated salivary flow rate (salivary flow rate < 0.7 mL/min). Secondary outcomes will include patient-reported xerostomia and quality of life, assessed using validated instruments. Conclusions: This study will provide comparative data on two PBM delivery approaches for the prevention of radiotherapy-induced hyposalivation and may contribute to the optimization of clinical protocols in oncological care.

  • Open Access

    Effect of Ozone Therapy on the Healing Process of Tooth Extractions in Smokers: A Randomized Split-Mouth Study

    by Eduardo Vidor Vieira, Carlos Laudevir Ferreira Júnior, Gabrielle Gonçalves dos Santos, Melissa Rodrigues Araújo, Reilá Tainá Mendes, Antonio Adilson Soares Lima, Maria Ângela Naval Machado

    Objective: To evaluate the effects of ozone therapy on pain control and wound healing following dental extractions in smokers. Material and Methods: This split-mouth clinical study included 42 hospitalized male smokers requiring bilateral tooth extraction. The sample was divided into a test and a control group (n = 14 per group). Test treatments included suturing with ozonated oil (OZO), application of ozone gas (OG), and irrigation with ozonated water (OW). The control group received irrigation with 0.9% saline solution. Analyzed variables included post-operative pain, healing progression, biofilm formation, surgical technique, and procedure duration. Pain was assessed using the Visual Analog Scale (VAS) on post-operative days 1, 2, and 3. Healing was clinically and photographically evaluated on days 0, 2, and 7. Biofilm presence, soft tissue inflammation, epithelial proliferation, and granulation tissue formation were analyzed through blinded image assessments. Statistical tests were applied to compare pain and healing outcomes. Results: All groups exhibited a significant reduction in pain by post-operative day 3 compared to day 1. On day 2, the OZO group showed significantly reduced pain and enhanced healing compared to the control. The OG group also demonstrated pain reduction. No significant differences were found in surgical technique or duration across groups. Conclusion: Ozonated oil and ozone gas effectively reduced post-operative pain in smokers, with ozonated oil also promoting superior wound healing by post-operative day 2.

  • Open Access

    Oral Manifestations of Pediatric Multisystem Inflammatory Syndrome

    by Angela Maira Guimarães, Waleska Tychanowicz Kolodziejwski, Camila Adriane Leffa, Priscila Queiroz Mattos da Silva, Juliana Lucena Schussel, Melissa Rodrigues de Araujo

    Background: Pediatric multisystem inflammatory syndrome (MIS‐C) is a rare condition associated with COVID‐19, with few reports on its oral manifestations. Case Report: A 13‐year‐old male pediatric patient with presented with fever, diarrhea, odynophagia, conjunctival hyperemia, rash, and bipalpebral edema. On physical examination, he exhibited diffuse ulcerated lesions with crusts on the vermilion border and labial mucosa, primarily affecting the labial commissures. Initially, immune‐mediated diseases such as erythema multiforme or Stevens–Johnson syndrome were suspected, and treatment with topical corticosteroids and photobiomodulation was initiated. However, the lesions worsened, and polymerase chain reaction (PCR) testing of a sample from the lesion confirmed herpes simplex virus type 1. Given the diagnosis, corticosteroid therapy was discontinued, and decontamination using antimicrobial photodynamic therapy (methylene blue 0.01%, 5 min, 660 nm, 100 mW, 6 J/point, energy density of 199.98 J/cm 2 ) was performed. However, oral lesions and overall systemic condition worsened, and the patient died. Conclusion: This case highlights the need for a differential diagnosis of oral lesions in MIS‐C in order to carry out the most appropriate treatment.

  • Diagnosis and management of a severe uremic stomatitis: Case report of multiple clinical features.

    by Marcela Andrade Ivanoski, Juliana Glaser Boal, Allan Fernando Giovanini, Antônio Adilson Soares de Lima, Melissa Rodrigues de Araujo


  • Evaluation of photobiomodulation therapy (PBMT) on salivary flow and composition in head and neck cancer patients undergoing radiation therapy

    by Natalia Schepanski, Floriatan Santos Costa, Edina Fernanda Martins Machado, Milena Nunes Pacheco, Clarice D.B. Amaral, Raquel C. Machado, Ana Rita A. Nogueira, João Armando Brancher, Laurindo Moacir Sassi, Melissa Rodrigues de Araujo


  • Fast recovery from Peripheral Facial Palsy in a patient with Ramsay-Hunt Syndrome using Photobiomodulation Therapy

    by Bárbara Soldatelli Ballardin, Allana Pivovar, Gabrieli Rodrigues de Almeida Abreu, Alyne Simões, Melissa Araujo

    Ramsay-Hunt syndrome is an infectious disease associated with the varicella-zoster virus, and peripheral facial palsy is often one of its clinical manifestations. Thi...